Copy number loss upstream of  uncovers gene expression regulatory region that may impact Potocki–Lupski syndrome diagnosis by unknown
Alaimo et al. Molecular Cytogenetics  (2015) 8:75 
DOI 10.1186/s13039-015-0179-7CASE REPORT Open AccessCopy number loss upstream of RAI1
uncovers gene expression regulatory
region that may impact Potocki–Lupski
syndrome diagnosis
Joseph T. Alaimo1, Sureni V. Mullegama1, Mary Ann Thomas2 and Sarah H. Elsea1*Abstract
The identification of structural variants of uncertain clinical significance is increasing; however, studies delineating
the functional consequence of these variants in the pathogenicity of phenotypic features are lacking. Understanding
the consequence of structural variants such as copy number alterations and their role in gene expression changes is
paramount in order to perform a comprehensive analysis of genetic effects on phenotypic variation and disease. RAI1 is
a dosage-sensitive essential neurodevelopmental gene. Copy number loss of RAI1 results in Smith-Magenis syndrome
while copy number gain results in Potocki-Lupski syndrome. Here, we present a case of a six year old female with a
newly identified maternally inherited copy number loss that lies within the Smith-Magenis syndrome common
deletion region, but RAI1 copy number is normal. Integration of the Encyclopedia of DNA Elements (ENCODE) data at
the affected region suggests that the deletion disrupts several cis-acting regulatory elements upstream of RAI1, such as
multiple repressor sites and an insulator region. Gene expression studies revealed that both the proband and the
mother have significantly elevated RAI1 mRNA levels suggesting that the structural variant alters gene expression
regulation. The proband and the mother both have some features of Potocki-Lupski syndrome, while the child appears
to be more affected with autistic-like features. Overall, our work demonstrates that the integration of ENCODE data
with structural variants of uncertain significance aids in delineating a functional consequence to a genomic aberration
and subsequent diagnosis.
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Chromosomal microarrays (CMA) have vastly changed
the identification of structural variants across the gen-
ome. CMA is considered a first-tier clinical diagnostic
test for individuals with idiopathic developmental delay,
intellectual disability, autism spectrum disorders, and
multiple congenital anomalies [1–4]. Determining the
clinical significance of variants identified through CMA
is challenging and requires the integration of informa-
tion across laboratories and experimental evidence pre-
sented in the literature. Furthermore, the identification
of novel structural variants confers an even greater* Correspondence: elsea@bcm.edu
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unknown primarily due to the lack of molecular and
functional studies required to implicate a genotype/
phenotype correlation.
The chromosomal locus 17p11.2 is an error prone re-
gion that frequently undergoes recombination events
resulting in genomic rearrangements. Within this region
lies retinoic acid-induced 1 (RAI1), a dosage-sensitive gene
responsible in the pathogenicity of Smith-Magenis syn-
drome (SMS, MIM 182290) when haploinsufficient and
Potocki-Lupski syndrome (PTLS, MIM 610883) when du-
plicated [5]. SMS is characterized by a distinct facial ge-
stalt, variable intellectual disability, early-onset of obesity,
inverted sleeping patterns, and a wide range of behavioral
problems including self-injury and stereotypies [5]. PTLS
phenotypic features are reportedly less comprehensiblyis distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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SMS, but most affected individuals present with variable
intellectual disability, autistic-like features, cardiovascular
malformations, and sleep apnea [6–8].
RAI1 is an essential neurodevelopmental gene that re-
quires tightly controlled regulation of expression tem-
porally and spatially [9], but the genetic landscape
encompassing the regulation of RAI1 gene expression
has largely been unexplored. Here, we characterized the
role of a newly identified maternally inherited deletion
proximal to RAI1 relative to RAI1 gene expression and
uncover, through the use of the Encyclopedia of DNA
Elements (ENCODE), the cis-regulatory regions that are
compromised, assigning functional consequence to the
genomic aberration.
Case presentation
A female proband (SMS448) came to our attention at
the age of six years because of behavioral problems and
global developmental delay. She was born to unrelated
parents of maternal Flemish, Norwegian, and Scandi-
navian descent and paternal Scottish and English des-
cent. She had an unremarkable prenatal history with no
reported maternal illness and was delivered at term with
no complications or need for resuscitation. At the time
of the visit, her height was between 50–75th percentile,
weight was at 97th percentile and head circumference
was at 50th percentile. She presented with several devel-
opmental issues including motor delay with associated
decreased strength, speech delay for which she received
speech therapy from 18 months to 3 years of age, sen-
sory integration disorder as diagnosed by occupational
therapy, socialization issues, sleep disturbance and re-
peated aggressive behavior when frustrated. Physical
examination revealed a square face, synophrys, deep-set
eyes, upslanting palpebral fissures, a prominent nasal root
and smooth philtrum. She was missing primary and adult
lateral incisors, had increased spacing between lower
probable central incisors, widely spaced nipples and thin
nails. A review at 9 years of age revealed improvement in
her development and behavior; however, she frequently
exhibited withdrawal or attention problems. She repeated
kindergarten but at this visit, was attending a regular
grade 3 class with no aide or extra support. Her growth
pattern and physical features remained consistent as her
first visit. The proband was referred for a possible diagno-
sis of Smith-Magenis syndrome based upon abnormal
array-CGH findings using CytoChip™ ISCA 8x60K v2.0
(BlueGnome). The DNA microarray analysis was per-
formed in a clinical cytogenetic laboratory and the re-
ported minimal coordinates for the abnormality were
arr[hg19] 17p11.2p11.2 (16,936,632–17,509,926)×1 and
the reported maximal coordinates for the abnormality
were arr[hg19] 17p11.2p11.2 (16,892,431–17,580,326)×1.Assessment of the origin of the deletion by fluorescence
in situ hybridization (FISH) revealed a maternally derived
deletion (SMS449). The paternal FISH result was normal
(data not shown). Siblings and maternal grandparents of
SMS448 were not tested, and it is not known whether any
harbor the copy number variant (CNV) (Fig. 1). This dele-
tion region lies within the SMS common interval and en-
compasses nine genes: MPRIP, PLD6, FLCN, COPS3,
NT5M, SMCR9, MED9, RASD1 and PEMT and also over-
laps with the region for the dominant genetic disorder,
Birt-Hogg-Dubé syndrome (BHDS, MIM 135150)
(Fig. 2, top). BHDS typically features fibrofolliculomas,
bilateral lung cysts, history of spontaneous pneumo-
thorax, and bilateral and multifocal renal tumors, but
family history was negative for any of these features. In-
dividuals with SMS who carry the common deletion
have a deletion of FLCN, and to date, no reports of
BHDS have been documented. An SMS individual with
a history of 3 spontaneous pneumothoraces has been re-
ported (but no other features of BHDS); however, se-
quence analysis revealed a missense mutation in FLCN
affecting transcript variant 2 [10]. There are no reports of
spontaneous pneumothorax or other features of BHDS in
PTLS patients. Furthermore, the other genes within the
deletion region have not been found to be associated with
other genetic disorders.
It is unclear whether such a deletion could be deleteri-
ous and manifest the phenotype present in this child.
However, the proband’s mother carries this deletion and
has reported learning difficulties and significant sensory
issues. Furthermore, other siblings of the proband, in-
cluding a full and maternal half sibling have a similar
hypersensitivity to textures and texture aversion behav-
ior, although they have not been assessed for the CNV
(Fig. 1). Phenotypic comparison of the proband to SMS
revealed some similarities, such as the motor and speech
delay, sensory issues, and increased weight. However, the
proximal breakpoint of the deletion falls distal to PEMT
but proximal to RAI1, resulting in normal copy number
of the causative gene for SMS. Reduced RAI1 mRNA ex-
pression is reported in SMS patients and can serve as an
additional molecular diagnostic indicator for the dis-
order [5]. Therefore, we evaluated whether the deletion
may affect RAI1 gene expression on peripheral blood
samples obtained from the proband, mother, father, and
normal controls.
Results and discussion
In order to establish RAI1 expression levels for compari-
son to our patient, we measured RAI1 mRNA levels in
lymphoblast cell lines from individuals with SMS and
PTLS. As expected, RAI1 mRNA levels were significantly
reduced in SMS samples (p = 0.0006) and overexpressed
in samples from individuals with PTLS (p < 0.0001)
Fig. 2 Genomic structure of 17p11.2 CNV and ChromHMM ENCODE regulatory sites. (Top) The maternally inherited deletion spans a maximum of
about 688 kb and encompasses 9 genes (white). Arrows represent gene orientation. (Bottom) Enlarged region of deletion shows that the maximum
distal breakpoint leaves RAI1 coding regions (white) intact. ChromHMM annotated regulatory sites within H1-hESC from ENCODE are labeled directly
underneath. Red = active promoter including transcriptional start site, pink = inactive promoter, dark grey = polycomb repressed, yellow = weak
enhancer, light green = low activity sites, and blue = insulator sites
Fig. 1 Pedigree of family with 17p11.2 deletion. The proband (SMS448) is denoted by arrow and carries a maternally inherited 17p11.2 deletion
(black semicircle) with intellectual delay (vertical lines) and severe texture aversion behavior (grey). A full-sibling and a half-sibling also display
severe texture aversion behavior (grey)
Alaimo et al. Molecular Cytogenetics  (2015) 8:75 Page 3 of 6
Fig. 3 RT-qPCR expression values of genes within and proximal to
17p11.2 deletion in SMS449 and SMS448. (a) RAI1 gene expression
values are significantly reduced in SMS and significantly elevated in
PTLS. Both the mother (SMS449) and the proband (SMS448) have
significantly elevated RAI1 mRNA levels relative to clinically normal
controls, while SMS448 also has significantly elevated levels relative
to SMS449. (b) PEMT in both SMS449 and SMS448 have significantly
reduced mRNA levels, similar to other individuals with SMS
deletions. PEMT levels in individuals with PTLS are significantly
elevated (c) FLCN levels are not compromised in either SMS449 and
SMS448 despite only having one copy. Results are similar to other
SMS deletions. Individuals with PTLS have significantly elevated
levels. Data are plotted as means +/-SEM. *p < 0.05 (relative to control)
†p < 0.05 (relative to SMS), #p < 0.05 (relative to PTLS), ^p < 0.05
(relative to SMS449)
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(SMS448) had a significant increase in RAI1 mRNA
levels of ~1.9 fold (p < 0.0001), while maternal (SMS449)
expression levels were also significantly elevated to ~1.4
fold relative to controls (p < 0.0001) (Fig. 3a). The pater-
nal RAI1 mRNA level was not significantly different
relative to other controls and therefore, was used as a
control sample (data not shown). Next, we tested the ex-
pression of two other genes in the deletion region toconfirm that reduction in gene dosage does alter mRNA
levels. First, we tested PEMT in both SMS448 and
SMS449 and found significantly reduced mRNA levels
relative to normal controls (SMS448; p = 0.0434,
SMS449 p = 0.0322) (Fig. 3b). The reduction of PEMT
mRNA levels was also observed in individuals with SMS
(p = 0.0026) but elevated in individuals with PTLS (p <
0.0001) (Fig. 3b). We also tested the expression level of
FLCN and surprisingly found that the mRNA levels were
not significantly compromised relative to normal con-
trols in either SMS448 or SMS449 (Fig. 3c). Similarly,
for SMS samples, we observed no expression changes in
FLCN, despite copy number loss, while a significant in-
crease in mRNA levels was found in PTLS samples (p <
0.0001) (Fig. 3c). Given the FLCN expression data and
the lack of clinical findings in both mother and child,
BHDS is not likely a medical concern. In summary, ex-
pression studies indicate that this particular deletion re-
gion increases RAI1 gene expression, which may lead to
some features observed in the proband and her mother.
However, the mechanism of altered RAI1 gene regula-
tion is unclear.
In order to further explore the possible impact of this
chromosomal deletion on the patient phenotype, we sur-
veyed the Database of Genomic Variants (DGV) and
found no deletions with identical coordinates to what is
observed in SMS448 and SMS449. Within the deletion
coordinates there are 33 reported deletions, while an-
other spans the proximal breakpoint and another spans
distal breakpoints and includes RAI1. Since the CNV
breakpoints may disrupt the genetic structure of RAI1
transcriptional regulatory elements, we utilized
ENCODE data to uncover how the regulatory landscape
may be altered. ENCODE includes data for the identifi-
cation and quantification of RNA molecules in whole
cells and sub-cellular compartments, mapping of
protein-coding regions, chromatin and DNA accessibil-
ity, mapping of histone modifications and transcription
binding sites, and DNA methylation status [11]. To un-
cover the putative regulatory region of RAI1, we specific-
ally focused on the chromatin state segmentation
analysis which includes the integration of ENCODE
ChIP-seq, DNAse-seq, and FAIRE-seq data using a
Hidden Markov Model (termed ChromHMM) in human
embryonic stem cells (hESC) [12]. Interestingly, we
found a variety of regulatory elements within the RAI1
coding sequence and upstream of the transcriptional
start site (Fig. 2, bottom). RAI1 has two non-coding
exons, and ChromHMM revealed two active promoter
sites within H1-hESC; one located within intron one
(Fig. 2, bottom, in red) and another in intron two (data
not shown). Furthermore, the first active promoter re-
gion is surrounded by repressor regions (dark grey) and
inactive but poised promoters (pink) (Fig. 2, bottom).
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portant developmental genes especially in hESC to have
a mixture of active and poised promoter regions. It is
thought that such a mixture serves the purpose for
achieving alternative developmental cell fates or lineages
[13]. The distal breakpoint of the CNV leaves most of
the promoter regions intact except for one region (Fig. 2,
Bottom). In addition, the deletion region also alters the
regulatory structure of repressor (dark grey), enhancer
(yellow) and insulator sites (blue) upstream of the RAI1
transcriptional start site (Fig. 2, bottom).
The net effect of such a loss in terms of RAI1 expres-
sion is unclear. The ENCODE data suggest that due to
its position within the regulatory landscape, the annotated
insulator site is likely blocking any upstream cis-acting en-
hancer site activity. However, the enhance regions are
“weak” due to the low detection of histone H3 lysine 4
methylation within this region, suggesting minimal impact
on expression. The abundant detection of histone H3 ly-
sine 27 tri-methylation, particularly around the promoter
region, provides strong evidence of polycomb-dependent
gene repression. Therefore, it is not surprising to observe
significantly elevated gene expression values of RAI1 in
both SMS448 and SMS449 based on this analysis (Fig. 3a).
There may be other mechanisms that are contributing to
the overexpression of RAI1. The genes that reside within
the genomic loss may lead to global transcriptome
changes which may include RAI1 itself or another gene in-
volved in regulating RAI1.
Some of the phenotypic features of SMS448 in con-
junction with gene expression data are suggestive of
PTLS. Previous studies have identified the smallest re-
gion of overlap of 17p11.2 duplications causing PTLS. In
this particular study, three patients with < 1 Mb duplica-
tion did not exhibit a phenotype distinct from PTLS nar-
rowing the genomic interval to include solely RAI1 and
surrounding regulatory sequences [8]. Examination of
SMS448 relative to these individuals revealed overlap-
ping features including normal growth measurements,
global developmental delay, intellectual delay, language
impairment, early behavioral issues with socialization
and aggression, sleep problems, sensory integration dis-
order, dysmorphic facial features, and dental abnormal-
ities. Interestingly, two of the three individuals initially
displayed poor scholastic performance requiring aid, but
were later enrolled in regular education classes similar
to SMS448. However, some of the other phenotypic hall-
marks of PTLS such as poor feeding as an infant, failure
to thrive and hypotonia as an infant were absent from
SMS448. Although, of the three only one individual dis-
played all three features while another only displayed
hypotonia as an infant. This information was unknown
for the third individual [8]. Therefore, RAI1 overexpres-
sion may be contributing to these features in SMS448.Interestingly, there are also reported cases describing
families of inherited PTLS, all of which are due to ma-
ternal transmission, and suggests that RAI1 overexpres-
sion is more tolerated than haploinsufficiency [7, 14].
It is also interesting to note that the proband
(SMS448) has higher RAI1 mRNA levels than what is
observed in her mother, SMS449 (p = 0.0003) (Fig. 3a).
One possible rationalization could be that SMS448 may
harbor another mutation in a gene that regulates RAI1
gene expression, but further molecular analysis is re-
quired. The other phenotypic features such as wide
spaced nipples, absence of both primary and secondary
lateral incisors, and fine hair and nails have not been re-
ported in PTLS and may potentially indicate the role of
an additional gene important for the development of tis-
sues arising from the ectoderm. There are a wide range
of ectodermal dysplasia disorders that have mild to se-
vere symptoms, but further investigation is required.
These additional phenotypic features may also be the
consequence of stochastic genome alterations directly
impacting gene expression and function [15].
Conclusions
In conclusion, we present a patient that carries a mater-
nally inherited deletion that results in significantly ele-
vated RAI1 mRNA levels,which likely contribute to the
overall phenotype including global developmental delay,
behavior, and dysmorphisms in this patient. Since no
other CNV was identified, additional testing such as
whole-exome sequencing will be required to determine
if the phenotypic features observed in this patient are
the result of mutation at more than one locus. Further-
more, future work utilizing and integrating ENCODE
data to infer function from newly reported genomic
structural variants may provide clinicians and re-
searchers an improved method for diagnosis.
Methods
Gene expression analysis
Peripheral blood samples were collected from SMS448
(proband), SMS449 (mother), SMS450 (father) and clin-
ically normal controls. In addition, we used patient
lymphoblast cell lines from Smith-Magenis syndrome
(SMS129, SMS123, SMS105), Potocki-Lupski syndrome
(SMS224 and GM23053) and controls (GM23054,
GM23055, GM22677). GM23053, GM23054, GM23055,
GM22677 were created by Coriell Cell Repositories
(Camden, NJ, USA). Total RNA was isolated according
to standard methods (Invitrogen, Carlsbad, CA), quanti-
fied using the NanoDrop® ND-100 Spectrophotometer,
and reverse transcribed with qSCRIPT cDNA SuperMix
(Quanta Biosciences, Inc., Gaithersburg, MD) according
to the manufacturer’s instructions. Real-time quantita-
tive PCR (RT-qPCR) was performed as previously
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gies, Carlsbad, CA) for RAI1 (Hs01554690_m1), FLCN
(Hs00376065_m1), PEMT (Hs00540979_m1), and
GAPDH (Hs9999905_m1) were used. GAPDH was used
as an endogenous control, and all cDNA samples were
run in triplicate in 10 uL reaction volumes and analyzed
using the BioRad CFX Connect™ Real-Time PCR Detec-
tion System. Results are expressed as fold-change relative
to normal controls, including the clinically normal father
(SMS450). Multiple comparisons were performed using
an ANOVA and Tukey’s post-hoc correction. Statistical
significance was determined at P < 0.05.
Bioinformatics
Array CGH analysis identified a copy number loss on
the short arm of chromosome 17 with the following
basepair coordinates; minimum, arr[hg18] 17p11.2p11.2
(16,877,357–17,450,651)×1 and maximum, arr[hg18]
17p11.2p11.2 (16,833,156–17,521,051)×1. Using the batch
coordinate conversion tool in Genome Browser (LiftOver:
https://genome.ucsc.edu/cgi-bin/hgLiftOver), both coordi-
nates were converted to GRCh37/hg19 resulting in
minimum deletion coordinates of chr17:16,936,632–
17,509,926 and maximum deletion coordinates of
chr17:16,892,431–17,580,326. We used the maximum
coordinates for the evaluation of the ENCODE data.
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